Eukaryotic elongation factor 2 kinase (eEF2K, eEF2-Kinase) is an oncogenic kinase overexpressed in various aggressive solid tumors, including triple-negative breast cancer, pancreatic, ovarian, and lung cancer. Here, EEF2K is linked to triple-negative breast carcinoma.